Since late February 2023 and up until 30 March 2023, 87 cases of botulism linked to intragastric injection of the botulinum neurotoxin (BoNT) have been reported.
Since late February 2023 and as of 10 March 2023, 67 cases of botulism linked to intragastric injection of the botulism neurotoxin (BoNT) have been reported in Germany (12), Austria (1), Switzerland (1) and Türkiye (53).
On 20 December 2016, ECDC and EFSA published a joint rapid outbreak assessment describing a cluster of six laboratory-confirmed German and Spanish cases of foodborne botulism caused by botulinum neurotoxin type E which occurred during November and December 2016. All of the six patients had consumed dried and salted roach, a fresh and brackish water fish (Rutilus rutilus).
On 8 March, the Health Protection Agency in the United Kingdom reported an additional fatal case of anthrax in Suffolk, England. It concerns a person who injected heroin. This brings the number of anthrax cases among injecting drug users in the EU to 14, since June 2012.
On 25 and 26 of July, two additional cases of soft-tissue anthrax among injecting drug users have been reported from the United Kingdom and Denmark. The genetic typing of the strains related to these cases is ongoing.